Literature DB >> 15065139

Coronary rotational atherectomy in current practice: acute and mid-term results in high- and low-volume centers.

Paolo Rubartelli1, Luigi Niccoli, Alessandro Alberti, Corinna Giachero, Federica Ettori, Bindo Missiroli, Guglielmo Bernardi, Luigi Maiello, Bernhard Reimers, Carmelo Cernigliaro, Gennaro Sardella, Ezio Bramucci.   

Abstract

We conducted a prospective observational study to evaluate the indications, technique, in-hospital and 9-month results of consecutive patients treated with rotational atherectomy (RA) in 12 centers during 1 year, as well as their relationship with volume of RA activity. The study included 345 lesions in 289 patients treated (4.4% +/- 2.6% of procedures at the participating centers). The lesions were mostly calcified (63%) and type B2 or C (74%). Procedural success was obtained in 94% of patients, with a major adverse cardiac event (MACE) rate of 4.5%. At 9 months, MACE occurred in 17.3%. Multivariate analysis identified multivessel disease and slow flow as negative predictors of procedural success, whereas balloon pressure <or= 6 atm and hypercholesterolemia were associated with decreased MACE at 9 months. Center RA volume was not associated with in-hospital or 9-month outcome. We conclude that RA, even when used sporadically in selected complex lesions, can provide good immediate and mid-term results. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15065139     DOI: 10.1002/ccd.20004

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  2 in total

1.  A New Era for Rotational Atherectomy: An Australian Perspective.

Authors:  Paul Bamford; Michael David Parkinson; Brendan Gunalingam; Michael David; George Tat-Ming Lau
Journal:  Clin Med Insights Cardiol       Date:  2019-06-07

2.  Reappraisal Value of a Modified Rotational Atherectomy Technique in Contemporary Coronary Angioplasty Era.

Authors:  Haojian Dong; Daisuke Hachinohe; Zhiqiang Nie; Yoshifumi Kashima; Jianfang Luo; Takuya Haraguchi; Hidemasa Shitan; Tomohiko Watanabe; Yutaka Tadano; Umihiko Kaneko; Takuro Sugie; Ken Kobayashi; Daitaro Kanno; Morio Enomoto; Katsuhiko Sato; Tsutomu Fujita
Journal:  J Interv Cardiol       Date:  2020-01-23       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.